MARKET

SEEL

SEEL

Seelos Therapeutics Inc
NASDAQ
0.4400
-0.0311
-6.60%
After Hours: 0.4499 +0.0099 +2.25% 19:55 07/26 EDT
OPEN
0.4770
PREV CLOSE
0.4711
HIGH
0.4993
LOW
0.4300
VOLUME
298.84K
TURNOVER
0
52 WEEK HIGH
398.40
52 WEEK LOW
0.4300
MARKET CAP
1.26M
P/E (TTM)
-0.0099
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SEEL last week (0715-0719)?
Weekly Report · 4d ago
'MDMA Therapy Gets Support From Prominent Research Group As FDA Weighs Action' - Green Market Report
23 medical doctors and researchers urged the FDA to accept MDMA therapy for PTSD. More than 17 U.S. Military veterans commit suicide each day due to PTSD. The paper noted that MDMA therapies have been proven safe and effective by multiple studies. The FDA is slated to rule on a new drug application for MDMA therapy by Aug. 11.
Benzinga · 07/16 18:51
Weekly Report: what happened at SEEL last week (0708-0712)?
Weekly Report · 07/15 12:10
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
SeaStar Medical Holding Corporation shares fell 34% to $8.55 on Wednesday. Virpax Pharmaceuticals, Inc. Shares jumped 139% in the mid-day session. The company entered into a $10 million registered direct offering of shares at $10.55 per share.
Benzinga · 07/10 17:18
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Ampco-Pittsburgh stock is rocketing more than 75% on commercial contract wins and backlog news. Vivopower shares are soaring over 54% on a new extended loan facility agreement. Seelos Therapeutics stock is surging more than 33% in pre-market trading. Biggest pre- market stock movers are new contracts and agreements.
Investorplace · 07/10 11:23
Why VivoPower International Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket
Shares of VivoPower International PLC rose sharply in today's pre-market trading. The company announced it secured an extension for a $34 million loan financing facility agreement. Ampco-Pittsburgh Corporation shares rose 72.6% to $1.32 in pre- market trading.
Benzinga · 07/10 09:34
Weekly Report: what happened at SEEL last week (0701-0705)?
Weekly Report · 07/08 12:13
Weekly Report: what happened at SEEL last week (0624-0628)?
Weekly Report · 07/01 12:13
More
About SEEL
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The Company operates under one segment which develops pharmaceutical products. The Company's programs include SLS-002 for the potential treatment of acute suicidal ideation and behavior (ASIB) in patients with major depressive disorder (MDD) and SLS-005 for the potential treatment of amyotrophic lateral sclerosis (ALS) and spinocerebellar ataxia (SCA). SLS-002 is intranasal racemic ketamine with two investigational new drug applications (INDs). SLS-005 is used for the potential treatment of Sanfilippo Syndrome. SLS-005 is IV trehalose, a protein stabilizer that crosses the blood-brain barrier and activates autophagy and the lysosomal pathway. The Company's ongoing preclinical programs include SLS-004, SLS-006, and SLS-007.

Webull offers Seelos Therapeutics Inc stock information, including NASDAQ: SEEL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SEEL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SEEL stock methods without spending real money on the virtual paper trading platform.